|
|
 | | | | | | | France
Indication: Divalproate de sodium (Depakote) is indicated for the treatment of manic episodes in patients suffering from bipolar disorder when the patient has a contraindication or intolerance to lithium.
Brand name: Depakote or Depakine.
Regulatory status: No indication registered in bipolar disorder.
Launch date: Not available.
| | | |
|
